Development of A Novel Class of Protein Conformation Selective Molecular Sensors

新型蛋白质构象选择性分子传感器的开发

基本信息

  • 批准号:
    1605225
  • 负责人:
  • 金额:
    $ 32.68万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
    Standard Grant
  • 财政年份:
    2016
  • 资助国家:
    美国
  • 起止时间:
    2016-07-01 至 2019-06-30
  • 项目状态:
    已结题

项目摘要

PI: Chi, EvaProposal No: 1605225This project will develop a novel class of sensors for the early detection and tracking of neurodegenerative disorders such as Alzheimer's and Parkinson's diseases. In particular, the sensors will detect the protein aggregates that form in the brain as early as two decades before the onset of symptoms. The ability to detect and track these protein aggregates will not only help in understanding the diseases better, but will also lead to early diagnosis and contribute towards the development of therapies to prevent and treat these devastating diseases. Misfolding and aggregation of proteins is a central pathogenic event in neurodegenerative disorders such as Alzheimer's and Parkinson's diseases, particularly the pre-fibrillar aggregate conformations that are the most neurotoxic, which is potentially due to a lack of molecular probes that could selectively and differentially target different protein aggregate conformations. To meet this critical need, development of a novel oligo(p-phenylene ethynylene) electrolytes (OPEs) for the direct sensing of the wide set of amyloid aggregates based on multiple "fluorescence turn-on" mechanisms is proposed. Compared to existing probes that are of limited clinical use, e.g., Thioflavin-T based probes, OPEs offer many distinct advantages, including versatile and highly tailorable structural and chemical properties, and most notably the multiple modes by which OPEs respond to interactions with ligands. Specifically, the researchers will synthesize and test OPEs for the in vitro detection of protein aggregates prepared from Alzheimer's and Parkinson's associated proteins (Objective 1). Experimental findings will also be synergistically combined with closely related computational modeling to gain a fundamental understanding of OPE-protein aggregate interactions as well as OPE's sensing mechanism. Such insights will be used to guide the rational design and synthesis of OPEs Ex vivo detection of amyloid aggregates in brain tissue sections (Objective 2) and in vivo detection in live Alzheimer's animal model brains (Objective 3). Molecular sensors developed in this project will give researchers the tool to simultaneously and dynamically track the protein misfolding and aggregation process for both in vitro and in vivo systems, facilitating research into the cause, diagnosis, and treatment of major neurodegenerative disorders. Additionally, the proposed multidisciplinary research will obligate the PIs to train graduate and undergraduates students in modern methodologies required to address important problems at the interface between chemistry, biology, engineering, and medicine. The acquired interdisciplinary skills will prepare students for careers in academe, national laboratories, and industry. The PIs also propose an ambitious plan to design and integrate "Biosensor Design Challenge Modules" into the core chemical engineering undergraduate curriculum at the University of New Mexico at all levels. The goal of this educational effort is two fold: 1. Improving student retention, particularly underrepresented minorities, and 2. Enhancing student success by providing opportunities for solving open-ended design problems throughout undergraduate education.
主要研究者:Chi,Eva提案编号:1605225该项目将开发一种新型传感器,用于早期检测和跟踪神经退行性疾病,如阿尔茨海默病和帕金森病。特别是,传感器将检测早在症状发作前二十年在大脑中形成的蛋白质聚集体。检测和跟踪这些蛋白质聚集体的能力不仅有助于更好地了解疾病,而且还将导致早期诊断,并有助于开发预防和治疗这些毁灭性疾病的疗法。 蛋白质的错误折叠和聚集是神经退行性疾病如阿尔茨海默病和帕金森病中的中心致病事件,特别是神经毒性最大的前纤维聚集体构象,这可能是由于缺乏可以选择性和差异性靶向不同蛋白质聚集体构象的分子探针。为了满足这一关键需求,提出了一种新的低聚(对亚苯基乙炔基)电解质(OPEs)的直接传感的广泛的淀粉样蛋白聚集体的基础上多个“荧光打开”机制的发展。与临床使用有限的现有探头相比,基于硫磺素-T的探针,OPEs提供了许多独特的优势,包括通用和高度可定制的结构和化学性质,最值得注意的是OPEs响应与配体相互作用的多种模式。具体来说,研究人员将合成和测试OPEs,用于体外检测由阿尔茨海默病和帕金森病相关蛋白制备的蛋白质聚集体(目标1)。实验研究结果也将与密切相关的计算建模协同结合,以获得对OPE-蛋白质聚集体相互作用以及OPE的传感机制的基本理解。这些见解将用于指导OPEs的合理设计和合成脑组织切片中淀粉样蛋白聚集体的离体检测(目标2)和活体阿尔茨海默病动物模型脑中的体内检测(目标3)。该项目开发的分子传感器将为研究人员提供工具,以同时动态跟踪体外和体内系统的蛋白质错误折叠和聚集过程,促进对主要神经退行性疾病的病因,诊断和治疗的研究。此外,拟议的多学科研究将责成PI培训研究生和本科生的现代方法,以解决化学,生物学,工程和医学之间的接口的重要问题。所获得的跨学科技能将为学生在国家实验室,国家实验室和行业的职业生涯做好准备。PI还提出了一个雄心勃勃的计划,设计和整合“生物传感器设计挑战模块”到核心化学工程本科课程在新墨西哥州的所有级别的大学。这项教育工作的目标有两个方面:1。提高学生的保留率,特别是代表性不足的少数民族,和2。通过在整个本科教育中提供解决开放式设计问题的机会来提高学生的成功率。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Eva Chi其他文献

Leveraging Students’ Funds of Knowledge in Chemical Engineering Design Challenges Supports Persistence Intentions
利用学生在化学工程设计挑战中的知识储备支持持久性意图
  • DOI:
    10.1021/acs.jchemed.1c00479
  • 发表时间:
    2021
  • 期刊:
  • 影响因子:
    3
  • 作者:
    Yan Chen;S. Kang;Jordan O. James;Eva Chi;Jamie R. Gomez;Sang;A. Datye;Vanessa Svihla
  • 通讯作者:
    Vanessa Svihla
Insights and Outcomes from a Revolution in a Chemical Engineering Department
化学工程系革命的见解和成果
The Educative Design Problem Framework: Relevance, Sociotechnical Complexity, Accessibility, and Nondeterministic High Ceilings
教育设计问题框架:相关性、社会技术复杂性、可访问性和不确定性上限
Pandemic Pivots Show Sustained Faculty Change
流行病的转折点显示教师的持续变化
Engineering Students’ Writing Perceptions Impact Their Conceptual Learning
工科学生的写作感知影响他们的概念学习

Eva Chi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Eva Chi', 18)}}的其他基金

Mechanism of Light-activated Antiviral Activity of Conjugated Polyelectrolyte Polymers and Oligomers
共轭聚电解质聚合物和低聚物的光激活抗病毒活性机制
  • 批准号:
    2105171
  • 财政年份:
    2021
  • 资助金额:
    $ 32.68万
  • 项目类别:
    Continuing Grant
Toxicity Mechanism of Biocidal Conjugated Polyelectrolyte Polymers and Oligomers
杀菌共轭聚电解质聚合物和低聚物的毒性机制
  • 批准号:
    1207362
  • 财政年份:
    2012
  • 资助金额:
    $ 32.68万
  • 项目类别:
    Continuing Grant
CAREER: Interface-induced misfolding and aggregation of intrinsically disordered proteins
职业:界面诱导的本质无序蛋白质的错误折叠和聚集
  • 批准号:
    1150855
  • 财政年份:
    2012
  • 资助金额:
    $ 32.68万
  • 项目类别:
    Standard Grant

相似国自然基金

Novel-miR-1134调控LHCGR的表达介导拟 穴青蟹卵巢发育的机制研究
  • 批准号:
  • 批准年份:
    2025
  • 资助金额:
    10.0 万元
  • 项目类别:
    省市级项目
novel-miR75靶向OPR2,CA2和STK基因调控人参真菌胁迫响应的分子机制研究
  • 批准号:
    82304677
  • 批准年份:
    2023
  • 资助金额:
    30.00 万元
  • 项目类别:
    青年科学基金项目
海南广藿香Novel17-GSO1响应p-HBA调控连作障碍的分子机制
  • 批准号:
    82304658
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
白术多糖通过novel-mir2双靶向TRADD/MLKL缓解免疫抑制雏鹅的胸腺程序性坏死
  • 批准号:
  • 批准年份:
    2021
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
novel-miR-59靶向HMGAs介导儿童早衰症细胞衰老的作用及机制研究
  • 批准号:
  • 批准年份:
    2021
  • 资助金额:
    58 万元
  • 项目类别:
    面上项目
novel_circ_008138/rno-miR-374-3p/SFRP4调控Wnt信号通路参与先天性肛门直肠畸形发生的分子机制研究
  • 批准号:
    82070530
  • 批准年份:
    2020
  • 资助金额:
    55 万元
  • 项目类别:
    面上项目
miRNA-novel-272通过靶向半乳糖凝集素3调控牙鲆肠道上皮细胞炎症反应的机制研究
  • 批准号:
    32002421
  • 批准年份:
    2020
  • 资助金额:
    24.0 万元
  • 项目类别:
    青年科学基金项目
m6A修饰介导的lncRNA WEE2-AS1转录后novel-pri-miRNA剪切机制在胶质瘤恶性进展中的作用研究
  • 批准号:
  • 批准年份:
    2020
  • 资助金额:
    55 万元
  • 项目类别:
    面上项目
miRNA/novel_167靶向抑制Dmrt1的表达在红鳍东方鲀性别分化过程中的功能研究
  • 批准号:
    31902347
  • 批准年份:
    2019
  • 资助金额:
    25.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Elucidation of the precise mechanism of heart failure prevention by beta-catenin inhibition enabling the future development of a novel class of medicine
阐明β-连环蛋白抑制预防心力衰竭的精确机制,有助于未来开发一类新型药物
  • 批准号:
    23K15167
  • 财政年份:
    2023
  • 资助金额:
    $ 32.68万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Development of first-in-class antagonists of the retinoid pathway as novel oral therapies for Type 2 Diabetes
开发类视黄醇途径的一流拮抗剂作为 2 型糖尿病的新型口服疗法
  • 批准号:
    10699637
  • 财政年份:
    2023
  • 资助金额:
    $ 32.68万
  • 项目类别:
Development of a novel class of ion channel blockers for the treatment of autoimmune disease
开发一类新型离子通道阻滞剂用于治疗自身免疫性疾病
  • 批准号:
    10053003
  • 财政年份:
    2023
  • 资助金额:
    $ 32.68万
  • 项目类别:
    Collaborative R&D
Pre-clinical development of a novel class of broad-spectrum natural product antivirals
一类新型广谱天然产物抗病毒药物的临床前开发
  • 批准号:
    480228
  • 财政年份:
    2023
  • 资助金额:
    $ 32.68万
  • 项目类别:
    Operating Grants
Development of first-in-class antagonists of the retinoid pathway as novel oral immunotherapies for solid cancers
开发类视黄醇途径的一流拮抗剂作为实体癌的新型口服免疫疗法
  • 批准号:
    10604218
  • 财政年份:
    2023
  • 资助金额:
    $ 32.68万
  • 项目类别:
Development of a novel class antibiotic for therapy of carbapenem-resistant Enterobacteriaceae
开发用于治疗碳青霉烯类耐药肠杆菌的新型抗生素
  • 批准号:
    82975
  • 财政年份:
    2021
  • 资助金额:
    $ 32.68万
  • 项目类别:
    Collaborative R&D
DEVELOPMENT OF A NOVEL CLASS OF ANTIBIOTICS AGAINST VIBRIO CHOLERAE NA+-NQR
新型抗霍乱弧菌 NA -NQR 抗生素的开发
  • 批准号:
    10367435
  • 财政年份:
    2021
  • 资助金额:
    $ 32.68万
  • 项目类别:
First-in-Human Clinical Development of a Novel Drug Candidate with a First-in-Class Mechanism for Smoking Cessation and Abstinence
具有一流戒烟和节欲机制的新候选药物的首次人体临床开发
  • 批准号:
    10452567
  • 财政年份:
    2021
  • 资助金额:
    $ 32.68万
  • 项目类别:
Advancing the development of a novel class of small molecules for treating pan-coronavirus infections
推进治疗泛冠状病毒感染的新型小分子的开发
  • 批准号:
    10672328
  • 财政年份:
    2021
  • 资助金额:
    $ 32.68万
  • 项目类别:
DEVELOPMENT OF A NOVEL CLASS OF ANTIBIOTICS AGAINST VIBRIO CHOLERAE NA+-NQR
新型抗霍乱弧菌 NA -NQR 抗生素的开发
  • 批准号:
    10540361
  • 财政年份:
    2021
  • 资助金额:
    $ 32.68万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了